Katelyn Emmett
Family · Burlington, VTNPI 1184195034
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Collegium Pharmaceutical, Inc. at 34.2% of the total. Reporting peaked in 2024 at $690 and has fallen 51.2% since, to $337 in 2025. Among family clinicians in VT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 108 payments — averaging $15.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$567
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$410
- AbbVie$178
- Azurity Pharmaceuticals, Inc.$169
- Averitas Pharma Inc.$66
- Pfizer$57
- plus $211 from 8 others
What the payments were for
- Food & beverage$1,658100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 51 | $567 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 23 | $410 |
| AbbVie | 7 | $178 |
| Azurity Pharmaceuticals, Inc. | 10 | $169 |
| Averitas Pharma Inc. | 3 | $66 |
| Pfizer | 3 | $57 |
| Idorsia Pharmaceuticals US Inc | 3 | $46 |
| Stemline Therapeutics Inc. | 1 | $33 |
| Lilly USA, LLC | 2 | $33 |
| Impel Pharmaceuticals Inc. | 1 | $21 |
| Ardelyx, Inc. | 1 | $20 |
| Vertex | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Upsher-smith Laboratories LLC | 1 | $19 |
How this compares
$1,658 in reported general payments places this provider in the 90th percentile of 75 family providers in Vermont.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 27 | $66,865 |
| Nucynta ErTapentadol Hcl | 15 | $26,837 |
| OxycontinOxycodone Hcl | 29 | $22,903 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 452 | $21,705 |
| Xtampza ErOxycodone Myristate | 22 | $13,731 |
| Oxycodone Hcl | 490 | $12,315 |
| Fentanyl | 71 | $11,999 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 412 | $11,295 |
| Buprenorphine | 39 | $9,476 |
| Lidocaine | 69 | $9,068 |
| LinzessLinaclotide | 16 | $8,496 |
| Morphine Sulfate ErMorphine Sulfate | 304 | $8,348 |
| MovantikNaloxegol Oxalate | 18 | $6,979 |
| Tramadol Hcl ErTramadol Hcl | 59 | $4,315 |
| Morphine Sulfate | 69 | $3,195 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $410 | $66,86527 claims |
| Collegium Pharmaceutical, Inc.Nucynta Er, Xtampza Er | $567 | $40,56837 claims |
| AbbVieLinzess | $178 | $8,49616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 75 family providers in Vermont.
Other family in Burlington
- Catherine FaldutoBurlington$2K
- Sarah DietschiBurlington$456
- Paul LarsonBurlington$231
- Marion FoleyBurlington$221
- Katrina BurksBurlington$130
- Isabelle UngerBurlington$78
- Karrie WilliamsBurlington$76
- Rachel GuyVergennes$36K
- Kristen SheehanRutland$4K
- Alyssa BrownRutland$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.